Cite

HARVARD Citation

    Clark, J. et al. (2015). Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2). Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online]. 
  
Back to record